Table 1 Demographic and clinical characteristics of study non-depressed MS patients (n = 112)
From: Insomnia among non-depressed multiple sclerosis patients: a cross-sectional study
Characteristics | N (%) |
|---|---|
Gender | |
Male | 40 (35.7) |
Female | 72 (64.3) |
Marital status | |
Single | 46 (41.1) |
Married | 62 (55.4) |
Divorced | 4 (3.6) |
Education level | |
Primary | 6 (5.4) |
Intermediate | 10 (8.9) |
Secondary | 20 (17.9) |
Bachelor | 64 (57.1) |
Postgraduate | 12 (10.7) |
Region | |
Southern | 34 (30.4) |
Middle | 42 (37.5) |
East | 24 (21.4) |
West | 12 (10.7) |
Age (years), mean ± SD 32.6 ± 8.9 | |
Age at disease onset (years), mean ± SD 26 ± 8.2 | |
Disease duration (years), mean ± SD 3.5 ± 1.9 | |
Number of admissions, mean ± SD 0.8 ± 1.3 | |
Number of attacks during last 2 years, mean ± SD 1.6 ± 1.9 | |
Medications used | |
Interferon beta-1b (betaferon) | 36 (32.1) |
Teriflunomide (aubagio) | 20 (17.9) |
Dimethylfumarate (tecfidera) | 24 (21.4) |
Rituximab (rituxan) | 18 (16.1) |
Alemtuzumab (lemetrada) | 14 (12.5) |
Routes of drug administration | |
Oral | 20 (17.9) |
Subcutaneous | 52 (46.4) |
Intramuscular | 32 (28.6) |
Intravenous | 8 (7.1) |